Allianz has co-led a funding round for Lendix, which will help the company to expand to additional countries across Europe by the end of the year.

The spinout has bagged support from Inserm Transfert Initiative and two Bpifrance-managed funds for its clinical-stage therapy for hepatitis B.

In 2016, Ava closed an oversubscribed $9.7m series A round backed by telecommunications company Swisscom and financial services provider Zurich Cantonal Bank.

BASF Venture Capital and Capagro have co-led a 10.7m funding round for the agricultural robot developer.

CMR Surgical, backed by ABB Technology Ventures, has added $100m in series B funding to its coffers.

Cambridge Innovation Capital has returned after backing CMR Surgical's two-tranche $46m series A round in 2016 and 2017.

The company will sell up to approximately 7.7 million shares priced at $22.8 to $28.7, valuing the Rocket Internet-backed business at $618m to $758m.

Cambridge spinout Crescendo Biologics has leveraged its transgenic protein discovery platform to license out an antibody to biopharmaceutical developer Zai Lab.

3P Learning held a 40% stake in Learnosity after having most recently invested $13.9m in 2016, but has now sold it to Battery Ventures.